PHAR

MKT CAP:$1B

Pharming Group N.V.

Market Cap

$1B

Healthcare·Biotechnology·🇳🇱 Netherlands·NASDAQ

Healthcare·Biotechnology·🇳🇱·NASDAQ

Stock Price

$17.54+$0.40 (+2.33%)

Apr 20, 2026

Company Details

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally....

CEO

Fabrice Chouraqui

IPO Date

Dec 23, 2020

Website

www.pharming.com

Key Metrics TTM

Revenue

$310M

— YoY

Net Income

$12M

EPS (Diluted)

$0.14

Free Cash Flow

$16M

Revenue / Share

$4.09

Gross Margin

87.7%

Operating Margin

3.2%

Net Margin

4.0%

FCF Margin

5.0%

P/S

3.8x

P/E

95.0x

Earnings Reports

Q1 2026

May 7, 2026

PENDING

FY 2025

Dec 30, 2025

$375MEPS $0.04

Q4 2025

Mar 12, 2026

$106MEPS $0.07

Q3 2024

Sep 29, 2024

$75MEPS -$0.02

Q2 2024

Jun 28, 2024

$74MEPS -$0.01

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 22	$55M	$53M	$8M
Q2 24	$74M	$66M	-$4M
Q3 24	$75M	$68M	$4M
Q4 25	$106M	$85M	$2M

Valuation

Quarter	P/S	P/E
Q3 22	—	—
Q2 24	—	—
Q3 24	—	—
Q4 25	3.7x	91.9x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 22	$13M	$13M
Q2 24	-$13M	-$13M
Q3 24	$10M	$9M
Q4 25	$7M	$7M

Capital Expenditures

Quarter	CapEx
Q3 22	$104.0K
Q2 24	$213.7K
Q3 24	$366.1K
Q4 25	$268.0K

CapEx

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 22	$2M	3.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q3 22	$13M	$12M	$21M
Q2 24	$22M	$16M	$33M
Q3 24	$21M	$15M	$29M
Q4 25	$32M	$23M	$37M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$171M	$0	$171M
Q2 22	$181M	$0	$181M
Q3 22	$193M	$0	$193M
Q4 22	$207M	$0	$207M
Q1 23	$170M	$0	$170M
Q2 23	$176M	$0	$176M
Q3 23	$52M	$135M	$187M
Q4 23	$62M	$152M	$213M
Q1 24	$48M	$139M	$187M
Q2 24	$44M	$106M	$150M
Q3 24	$61M	$111M	$172M
Q4 24	$55M	$113M	$168M
Q1 25	$60M	$47M	$107M
Q2 25	$95M	$34M	$129M
Q3 25	$113M	$29M	$142M
Q4 25	$145M	$34M	$179M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 22	87M	—	—
Q2 24	85M	-2.0%	—
Q3 24	65M	-23.8%	—
Q4 25	76M	+17.2%	—

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 22	$199.8K	277
Q2 24	$193.8K	382
Q3 24	$195.9K	382
Q4 25	$262.1K	404

Revenue / Employee